Additionally, analysis of data from Taiwanese individuals in the TCGA database revealed that hypermethylation of transmembrane protein 240 (TMEM240) is associated with poor hormone therapy response in patients with breast cancer [22]. The gene discussed is TMEM240; the disease is breast carcinoma.